Research Support, Non-U.S. Gov't
- Novel Pathogenetic Mechanism in a Clinical Isolate of Yersinia enterocolitica KU14
-
Yoshinori Sato , Kenichi Kaneko , Takeshi Sasahara , Matsuhisa Inoue
-
J. Microbiol. 2006;44(1):98-105.
-
DOI: https://doi.org/2330 [pii]
-
-
Abstract
- Yersinia enterocolitica induces a broad range of gastrointestinal syndromes, including acute
enteritis. We previously reported that the clinical isolate, Y. enterocolitica KU14, which lacks
pYV, was still capable of causing clinical infection. The present study demonstrated that KU14
did not trigger the death of macrophages in vitro, unlike WA-314 (ATCC51871, which harbors
the pYV virulence plasmid). However, the intracellular growth of KU14 in the macrophages was
greater than that of WA-C (ATCC51872, a non-plasmid harboring the derivative pYV plasmid).
Treatment with a cholesterol-binding drug (β-cyclodextrin) that affected lipid rafts resulted in a
dramatic reduction in the intracellular growth of KU14. These data clearly indicate that the enhanced
intracellular growth of KU14 is related to lipid raft-mediated infection.